Open Access Peer-reviewed Research Article

Main Article Content

Pitchou Mukaz Mbey
Dieudonné Moliwa Moningo
Augustin Mukakala Kibonge
Patrick Zihalirwa Ciza
Igor Mujinga Wa Mujinga
Manix Banza Ilunga
Gabriel Waratch Unen Wakunga
Olivier Mukuku corresponding author
Willy Kalau Arung


Objective: To analyze the practices of general practitioners (GPs) in terms of recommendations on individual screening for prostate cancer (PCa).
Methods: An anonymous cross-sectional survey using a pre-established questionnaire was conducted among 193 GPs in the city of Lubumbashi from May 1st to July 31st, 2020. The questionnaire included three parts: identity criteria of GPs, screening practice and the opinion of GPs on the recommendations.
Results: The participation rate was 79%. Eighty-two-point nine percent of respondents said they offered screening for PCa; 42.5% of them said they offered this screening to all men within a certain age limit, ranging between 50 to 75 years in 38.8% of the cases. Only 12.5% of GPs provided complete prior information to their patients. Thirty-six-point three percent of GPs reported combining digital rectal examination with total PSA testing, but in the presence of an abnormality, 60.6% reported that they referred their patients directly to the urologist without ordering other additional investigations (first or second line). Finally, 32.7% of GPs found that the recommendations disseminated were appropriate for their practice.
Conclusion: Individual screening for PCa is widely proposed; but there are differences between the practices reported by GPs and official recommendations of learned societies. Our study highlights the need to popularize the recommendations of learned societies to GPs.

prostate cancer, individual screening, general practitioner

Article Details

How to Cite
Mbey, P., Moningo, D., Kibonge, A., Ciza, P., Mujinga, I., Ilunga, M., Wakunga, G., Mukuku, O., & Arung, W. (2021). Individual prostate cancer screening: Practice survey with general practitioner of Lubumbashi, Democratic Republic of Congo. Current Cancer Reports, 3(1), 95-100.


  1. Mbey P, Mukuku O, Arung W, et al. Clinical, histopathological and prognostic characteristics of patients with prostate cancer in Lubumbashi, Democratic Republic of Congo. Prostate Cancer, 2020.
  2. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized european study. The New England Journal of Medicine, 2009, 360: 1320-1328.
  3. Andriole GL, Crawford EF, Grubb 3rd RL, et al. Mortality results from a randomized prostate-cancer screening. The New England Journal of Medicine, 2009, 360: 1310-1319.
  4. 4. Agence nationale d’accréditation et d’évaluation en santé (Anaes). Éléments d’information des hommes envisageant la réalisation d’un dépistage individuel du cancer de la prostate. Recommandations pour la pratique clinique. Septembre 2004.
  5. Francois T, Alezra E, Kikassa JC, et al. Screening of prostate cancer seen by general practitioners. Progr`es en urologie, 2013, 23(16) : 1407-1411.
  6. Guy L, Van De Steene E, V´edrine N, et al. General practical survey of individual prostate cancer screening. Progr`es en urologie, 2008, 18(1): 46-52.
  7. El Fakir S, Abda N, Najdi A, et al. Cancer Screening Practices of Physicians Working in the Fez Prefecture Health Center (Mo-rocco). Sante Publique, 2013, 25(5): 685-691.
  8. Brett J, Watson E, Hewitson P, et al. PSA testing for prostate cancer: an online sur-vey of the views and reported practice of general practitioners in the UK. BMC Family Practice, 2005, 6: 24-29.
  9. Durham J, Low M and Mc Leod D. Screening for prostate cancer: a survey of the New Zealand general practitioners. The New Zealand Medical Journal, 2003, 116: U476.
  10. Ganry O and Boche T. Pr´evention des cancers par les m´edecins g´en´eralistes de Picardie: r´esultats d’une enquˆete de type d´eclarative. Bull Cancer, 2004, 91(10): 785-791.
  11. Praz V, Jichlinski P, Aymon D, et al. D´epistage du cancer de la prostate. Instantan´e d’une pratique quotidienne parmi 300 m´edecins g´en´eralistes dans le canton de Vaud. Revue M´edicale Suisse, 2005, 1: 2840-2842.
  12. Ganry O and Boche T. Pr´evention des cancers par les m´edecins g´en´eralistes de Picardie: r´esultats d’une enquˆete de type d´eclarative. Bull Cancer, 2004, 91(10): 785-791.
  13. Burin B, Bouchot O and Rigaud J. Pratiques des m´edecins g´en´eralistes de Loire-Atlantique et connaissances de leurs patients sur le d´epistage du cancer de la prostate. Prog Urol, 2006, 16: 559-563.
  14. Lamplugh M, Gilmore P, Quinlan T, et al. PSA testing: are patients aware of what lies ahead? Annals of The Royal College of Surgeons of England, 2006, 88(3): 284-288.
  15. 15. Garcia-Giannoli H, Sasco AJ. Prévention des cancers par les médecins généralistes de Rhône: résultats d’une enquête de type déclarative. Bull Cancer, 1996, 83: 853-863.